EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 3.0

Secretagogue laxatives as a potential strategy to overcome adherence barriers to over-the-counter treatment for clozapine-induced constipation

Jonathan G Leung iD, Matej Markota iD, Xiao Jing Wang iD

Mental Health Clinician · 2026-08 · 16 (4) · 207-216

DOI: 10.9740/mhc.2026.08.207 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Mental Health Clinician, 2026-08. Verfasst von Jonathan G Leung und 2 weiteren Autor:innen. Beteiligte Einrichtung: (Corresponding author) Pharmacist, Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, Leung.jonathan@Mayo.edu. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Clozapine-induced constipation may occur in at least 60% of patients, with first-line options typically involving polyethylene glycol or sennosides. However, there may be adherence barriers to an over-the-counter bowel regimen due to the dosage form, lack of insurance coverage, or lack of benefit. One possible solution to address these adherence barriers may include prescribing a secretagogue laxative. However, there is limited literature supporting the use of secretagogue laxatives in clozapine-associated constipation. A case series is presented in which adherence barriers impeded the use of over-the-counter laxatives, and a secretagogue laxative was implemented to manage clozapine-induced constipation. Case Report In 4 cases, lubiprostone or linaclotide was initiated, either as monotherapy or in combination with over-the-counter laxatives. Reasons for secretagogue laxative initiation included: (1) reducing a complex over-the-counter laxative regimen, (2) a lack of insurance coverage of over-the-counter laxatives, (3) dissatisfaction with polyethylene glycol’s palatability, and (4) cognitive impairment leading to decreased adherence to polyethylene glycol.

Discussion

It is important that clozapine-induced constipation is managed adequately to prevent severe consequences of gastrointestinal hypomotility. In addition to timely initiation and titration of constipation pharmacotherapy, adherence should be assessed. When adherence barriers to the use of over-the-counter laxatives are present, the use of a secretagogue laxative may be an option, recognizing there is limited evidence to guide this decision.

Conclusion

In these cases, adherence barriers to over-the-counter laxatives were identified. A secretagogue laxative was implemented, well-tolerated, and able to be continued for the duration of follow-up.

Schlagwörter

Stichwörter der Autor:innen

clozapineconstipationgastrointestinal hypomotilitylinaclotidelubiprostonepolyethylene glycolsennosides

Autor:innen und Institutionen

  • (Corresponding author) Pharmacist, Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, Leung.jonathan@Mayo.edu.
  • Consultant, Assistant Professor, Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota.
  • Consultant, Associate Professor, Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

ORCID-Profile: Jonathan G Leung, Matej Markota, Xiao Jing Wang

Zitieren

APA

Leung, J. G., Markota, M., & Wang, X. J. (2026). Secretagogue laxatives as a potential strategy to overcome adherence barriers to over-the-counter treatment for clozapine-induced constipation. Mental Health Clinician, 16(4), 207-216. https://doi.org/10.9740/mhc.2026.08.207

Vancouver

Leung JG, Markota M, Wang XJ. Secretagogue laxatives as a potential strategy to overcome adherence barriers to over-the-counter treatment for clozapine-induced constipation. Mental Health Clinician. 2026;16(4):207-216. doi:10.9740/mhc.2026.08.207

BibTeX
@article{Leung2026,
  author = {Leung, Jonathan G and Markota, Matej and Wang, Xiao Jing},
  title = {Secretagogue laxatives as a potential strategy to overcome adherence barriers to over-the-counter treatment for clozapine-induced constipation},
  journal = {Mental Health Clinician},
  year = {2026},
  volume = {16},
  number = {4},
  pages = {207--216},
  doi = {10.9740/mhc.2026.08.207}
}
Kostenlos starten →